Literature DB >> 2804981

Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells.

W Siegrist1, F Solca, S Stutz, L Giuffrè, S Carrel, J Girard, A N Eberle.   

Abstract

Receptors for alpha-melanocyte-stimulating hormone (alpha-MSH) on human malignant melanoma cell lines were investigated with a specific binding assay and characterized with structural analogues of alpha-MSH and adrenocorticotropic hormone and by photoaffinity cross-linking of the hormone-receptor complex. Specific binding of high-performance liquid chromatography-purified, monoiodinated alpha-MSH in the presence of 1 mM 1,10-phenanthroline as protease inhibitor was highest after a 2-h incubation at 37 degrees C. The nonspecific binding was less than 20% and dissociation of the ligand-receptor complex was relatively slow. Ten out of 12 human cell lines showed specific binding sites for alpha-MSH with Kp values ranging from 0.195 to 2.87 nM and the sites/cell being approximately 400 to approximately 1600. Virtually identical results were obtained in an assay where the cells remained attached to the culture dishes during the entire experiment. The study of hormone analogues with the D10 cell line showed that oxidized alpha-MSH had an approximately 40-fold lower affinity than alpha-MSH whereas [Nle4,D-Phe7]-alpha-MSH displayed a threefold and the adrenocorticotropic hormone fragments (1-17) and (1-24) a 20- and 8-fold higher affinity. Cross-linking of the alpha-MSH-receptor complex of three cell lines using monoiodinated [Nle4,D-Phe7,Trp(2-nitro-4-azidophenylsulfenyl)9]-alpha-MSH as photoaffinity label revealed a major Mr 45,000 protein band on sodium dodecyl sulfate-polyacrylamide gels, analogous to the MSH receptor of mouse B16 melanoma cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2804981

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  64 in total

1.  Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1.

Authors:  Gang Ren; Shuanlong Liu; Hongguang Liu; Zheng Miao; Zhen Cheng
Journal:  Bioconjug Chem       Date:  2010-11-12       Impact factor: 4.774

2.  Replacement of the Lys linker with an Arg linker resulting in improved melanoma uptake and reduced renal uptake of Tc-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide.

Authors:  Jianquan Yang; Haixun Guo; R Steve Padilla; Marianne Berwick; Yubin Miao
Journal:  Bioorg Med Chem       Date:  2010-08-01       Impact factor: 3.641

3.  Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor.

Authors:  P Agretti; G De Marco; D Sansone; C Betterle; G Coco; A Dimida; E Ferrarini; A Pinchera; P Vitti; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2010-03-22       Impact factor: 4.256

4.  Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.

Authors:  Lihui Wei; Xiuli Zhang; Fabio Gallazzi; Yubin Miao; Xiaofang Jin; Martin W Brechbiel; Heng Xu; Thomas Clifford; Michael J Welch; Jason S Lewis; Thomas P Quinn
Journal:  Nucl Med Biol       Date:  2009-03-26       Impact factor: 2.408

5.  Receptor-mediated transcytosis: a mechanism for active extravascular transport of nanoparticles in solid tumors.

Authors:  Wei Lu; Chiyi Xiong; Rui Zhang; Lifang Shi; Miao Huang; Guodong Zhang; Shaoli Song; Qian Huang; Gang-Yu Liu; Chun Li
Journal:  J Control Release       Date:  2012-05-14       Impact factor: 9.776

6.  Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.

Authors:  Lihui Wei; Yubin Miao; Fabio Gallazzi; Thomas P Quinn; Michael J Welch; Amy L Vāvere; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2007-09-04       Impact factor: 2.408

7.  Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma.

Authors:  Wissam Beaino; Jessie R Nedrow; Carolyn J Anderson
Journal:  Mol Pharm       Date:  2015-05-08       Impact factor: 4.939

Review 8.  Malignant melanoma and melanocortin 1 receptor.

Authors:  A A Rosenkranz; T A Slastnikova; M O Durymanov; A S Sobolev
Journal:  Biochemistry (Mosc)       Date:  2013-11       Impact factor: 2.487

9.  Imaging human melanoma using a novel Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptide.

Authors:  Liqin Liu; Jingli Xu; Jianquan Yang; Changjian Feng; Yubin Miao
Journal:  Bioorg Med Chem Lett       Date:  2016-08-17       Impact factor: 2.823

10.  PET of malignant melanoma using 18F-labeled metallopeptides.

Authors:  Gang Ren; Zhe Liu; Zheng Miao; Hongguang Liu; Murugesan Subbarayan; Frederick T Chin; Lan Zhang; Sanjiv S Gambhir; Zhen Cheng
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.